XNCR - Xencor, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.64
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$28.75
DETAILS
HIGH:
$42.00
LOW:
$18.00
MEDIAN:
$27.50
CONSENSUS:
$28.75
UPSIDE:
143.44%
Market Cap:
843.36M
Volume:
463,544
Avg Volume:
691,829
52 Week Range:
6.92-18.69
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.97
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
250
IPO Date:
2013-12-03
EPS (TTM):
-3.58
P/E Ratio:
-6.43
Revenue (TTM):
110.49M
Total Assets:
951.95M
Total Debt:
231.95M
Cash & Equiv:
40.88M
Rev Growth (5Y):
-6.7%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-22.9%
Debt/Equity:
0.34
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $-0.08 | $-0.72 | +88.9% | $21.0M | $30.0M | -29.9% |
| 2025-08-06 | $-0.41 | $-0.78 | +47.4% | $43.6M | $24.4M | +78.9% |
| 2025-05-07 | $-0.66 | $-0.63 | -4.8% | $32.7M | $22.5M | +45.5% |
| 2025-02-27 | $-0.62 | $-0.81 | +23.5% | $70.0M | $16.9M | +313.3% |
| 2024-11-06 | $-0.71 | $-0.98 | +27.6% | $10.7M | $16.6M | -35.6% |
| 2024-08-05 | $-1.07 | $-0.85 | -25.9% | $17.0M | $15.8M | +7.1% |
| 2024-05-09 | $-1.11 | $-0.76 | -46.1% | $12.8M | $25.0M | -48.8% |
| 2024-02-27 | $-0.31 | $0.36 | -186.1% | $44.7M | $73.8M | -39.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 110.49M | 174.62M | 164.58M | 275.11M | 122.69M | 156.70M | 40.60M | 35.71M | 87.52M | 27.76M | 9.52M | 10.17M |
| Net Income | (232.62M) | (133.13M) | (55.18M) | 82.63M | (69.33M) | 26.88M | (70.41M) | (48.92M) | 23.62M | (17.59M) | (16.42M) | (60.26M) |
| EPS | -3.58 | -2.08 | -0.93 | 1.42 | -1.11 | 0.48 | -1.31 | -1.05 | 0.57 | -0.45 | -0.52 | -1.92 |
| Total Assets | 951.95M | 952.69M | 846.27M | 838.21M | 703.24M | 670.25M | 576.73M | 390.10M | 428.56M | 206.91M | 67.82M | 87.31M |
| Total Debt | 231.95M | 83.43M | 59.63M | 33.97M | 11.63M | 10.73M | 0 | 0 | 0 | 0 | 0 | 9,000 |
| Cash & Equivalents | 40.88M | 53.79M | 53.94M | 143.48M | 163.54M | 50.31M | 26.25M | 16.53M | 14.53M | 12.59M | 54.65M | 77.97M |
| Operating Cash Flow | (202.19M) | (77.93M) | 24.48M | (16.85M) | (5.00M) | 64.37M | (79.76M) | (33.68M) | 94.62M | 26.67M | (21.35M) | (5.45M) |
| Free Cash Flow | (208.28M) | (96.37M) | (18.92M) | (32.83M) | (18.77M) | 53.34M | (88.90M) | (40.96M) | 91.61M | 22.99M | (23.64M) | (6.75M) |
| FCF per Share | -3.20 | -1.59 | -0.32 | -0.56 | -0.33 | 0.94 | -1.65 | -0.87 | 2.22 | 0.59 | -0.75 | -0.22 |
| Book Value | 677.61M | 668.80M | 727.50M | 733.50M | 572.44M | 593.20M | 521.68M | 282.05M | 313.95M | 162.43M | 59.29M | 73.53M |
| Cash & ST Investments | 497.77M | 593.73M | 623.06M | 334.11M | 603.00M | 527.08M | 294.36M | 224.13M | 130.14M | 96.43M | 54.65M | 77.97M |
| ROC Equity | -0.34 | -0.20 | -0.08 | 0.11 | -0.12 | 0.05 | -0.13 | -0.17 | 0.08 | -0.11 | -0.28 | -0.82 |